Around 50 million people are affected by Alzheimer’s disease across the globe, and it is likely to present an increasing demand for the innovation of small molecules for this type of dementia (World Health Organization, 2020).3 Acetylcholinesterase (AChE) is an enzyme that catalyzes acetylcholine hydrolysis. The gene discussed is ACHE; the disease is Alzheimer disease.